Stat1 expression is not sufficient to regulate the interferon signaling pathway in cellular immortalization

Journal of Interferon and Cytokine Research

Volumn 26, Issue 1, 2006, Pages 14-26

  Tang, Lin ^a   Roberts, Paul C ^a   Kraniak, Janice M ^a   Li, Qunfang ^a   Tainsky, Michael A ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; STAT1 PROTEIN;

ARTICLE; CARCINOGENESIS; CELL IMMORTALIZATION; CELL PROLIFERATION; DNA METHYLATION; EPIGENETICS; FAMILIAL CANCER; FIBROBLAST; GENE EXPRESSION REGULATION; GENE MUTATION; GENE SILENCING; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL AGING; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; DNA METHYLATION; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERFERONS; LI-FRAUMENI SYNDROME; PROMOTER REGIONS (GENETICS); SEQUENCE ANALYSIS, DNA; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR;

EID: 32044442304     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2006.26.14     Document Type: Article

References (80)

1. Stampfer MR, Yaswen P. Human epithelial cell immortalization as a step in carcinogenesis. Cancer Lett. 2003;194:199-208.
2. Lundberg AS, Hahn WC, Gupta P, Weinberg RA. Genes involved in senescence and immortalization. Curr. Opin. Cell Biol. 2000; 12:705-709.
3. Olovnikov AM. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J. Theor. Biol. 1973;41:181-190.
4. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O, Peacocke M, Campisi J. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 1995;92:9363-9367.
5. Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J. 1995;14:4240-4248.
6. Reddel RR. The role of senescence and immortalization in carcinogenesis. Carcinogenesis 2000;21:477-484.
7. Gollahon LS, Kraus E, Wu TA, Yim SO, Strong LC, Shay JW, Tainsky MA. Telomerase activity during spontaneous immortalization of Li-Fraumeni syndrome skin fibroblasts. Oncogene 1998;17:709-717.
8. Kulaeva OI, Draghici S, Tang L, Kraniak JM, Land SJ, Tainsky MA. Epigenetic silencing of multiple interferon pathway genes after cellular immortalization. Oncogene 2003;22:4118-4127.
9. Pestka S, Langer JA, Zoon KC, Samuel CE. Interferons and their actions. Annu. Rev. Biochem. 1987;56:727-777.
10. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. How cells respond to interferons. Annu. Rev. Biochem. 1998;67: 227-264.
11. Platanias LC, Fish EN. Signaling pathways activated by interferons. Exp. Hematol. 1999;27:1583-1592.
12. Platanias LC. Interferons: laboratory to clinic investigations. Curr. Opin. Oncol. 1995;7:560-565.
13. Imada K, Leonard WJ. The Jak-Stat pathway. Mol. Immunol. 2000;37:1-11.
14. Leonard WJ, O'Shea JJ. Jaks and Stats: biological implications. Annu. Rev. Immunol. 1998;16:293-322.
15. Uddin S, Gardziola C, Dangat A, Yi T, Platanias LC. Interaction of the c-cbl proto-oncogene product with the Tyk-2 protein tyrosine kinase. Biochem. Biophys. Res. Commun. 1996;225:833-838.
16. Takaoka A, Tanaka N, Mitani Y, Miyazaki T, Fujii H, Sato M, Kovarik P, Decker T, Schlessinger J, Taniguchi T. Protein tyrosine kinase Pyk2 mediates the Jak-dependent activation of MAPK and Stat1 in IFN-gamma, but not IFN-alpha, signaling. EMBO J. 1999;18:2480-2488.
17. Pitha PM. Introduction: interferon's connection to cancer. Semin. Cancer Biol. 2000;10:69-72.
18. Liang G, Gonzales FA, Jones PA, Orntoft TF, Thykjaer T. Analysis of gene induction in human fibroblasts and bladder cancer cells exposed to the methylation inhibitor 5-aza-2′-deoxycytidine. Cancer Res. 2002;62:961-966.
19. Karpf AR, Peterson PW, Rawlins JT, Dalley BK, Yang Q, Albertsen H, Jones DA. Inhibition of DNA methyltransferase stimulates the expression of signal transducer and activator of transcription 1, 2, and 3 genes in colon tumor cells. Proc. Natl. Acad. Sci. USA 1999;96:14007-14012.
20. Agrawal S, Agarwal ML, Chatterjee-Kishore M, Stark GR, Chisolm GM. Stat1-dependent, p53-independent expression of p21(waf1) modulates oxysterol-induced apoptosis. Mol. Cell. Biol. 2002;22:1981-1992.
21. Chin YE, Kitagawa M, Kuida K, Flavell RA, Fu XY. Activation of the Stat signaling pathway can cause expression of caspase 1 and apoptosis. Mol. Cell. Biol. 1997;17:5328-5337.
22. Xu X, Fu XY, Plate J, Chong AS. IFN-gamma induces cell growth inhibition by Fas-mediated apoptosis: requirement of Stat1 protein for up-regulation of Fas and FasL expression. Cancer Res. 1998;58:2832-2837.
23. Kaplan DH, Shankaran V, Dighe AS, Slockert E, Aguel M, Old LJ, Schreiber RD. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc. Natl. Acad. Sci. USA 1998;95:7556-7561.
24. Huang S, Bucana CD, Van Arsdall M, Fidler IJ. Stat1 negatively regulales angiogenesis, tumorigenicity and metastasis of tumor cells. Oncogene 2002;21:2504-2512.
25. Pereira-Smith OM, Smith JR. Genetic analysis of indefinite division in human cells: identification of four complementation groups. Proc. Natl. Acad. Sci. USA 1988;85:6042-6046.
26. Sugawara O, Oshimura M, Koi M, Annab LA, Barrett JC. Induction of cellular senescence in immortalized cells by human chromosome 1. Science 1990;247:707-710.
27. Hensler PJ, Annab LA, Barrett JC, Pereira-Smith OM. A gene involved in control of human cellular senescence on human chromosome 1q. Mol. Cell. Biol. 1994;14:2291-2297.
28. Yawata T, Kamino H, Kugoh H, Katoh M, Nomura N, Oishi M, Horikawa I, Barrett JC, Oshimura M. Identification of a ≤600-kb region on human chromosome 1q42.3 inducing cellular senescence. Oncogene 2003;22:281-290.
29. Ning Y, Weber JL, Killary AM, Ledbetter DH, Smith JR, Pereira-Smith OM. Genetic analysis of indefinite division in human cells: evidence for a cell senescence-related gene(s) on human chromosome 4. Proc. Natl. Acad. Sci. USA 1991;88:5635-5639.
30. Sandhu AK, Hubbard K, Kaur GP, Jha KK, Ozer HL, Athwal RS. Senescence of immortal human fibroblasts by the introduction of normal human chromosome 6. Proc. Natl. Acad. Sci. USA 1994;91: 5498-5502.
31. Ogata T, Oshimura M, Namba M, Fujii M, Oishi M, Ayusawa D. Genetic complementation of the immortal phenotype in group D cell lines by introduction of chromosome 7. Jpn. J. Cancer Res. 1995;86:35-40.
32. Ogata T, Ayusawa D, Namba M, Takahashi E, Oshimura M, Oishi M. Chromosome 7 suppresses indefinite division of nontumorigenic immortalized human fibroblast cell lines KMST-6 and SUSM-1. Mol. Cell. Biol. 1993;13:6036-6043.
33. Kumata M, Shimizu M, Oshimura M, Uchida M, Tsutsui T. Induction of cellular senescence in a telomerase negative human immortal fibroblast cell line, LCS-AF.1-3, by human chromosome 6. Int. J. Oncol. 2002;21:851-856.
34. Vojta PJ, Futreal PA, Annab LA, Kato H, Pereira-Smith OM, Barrett JC. Evidence for two senescence loci on human chromosome 1. Genes Chromosomes Cancer 1996;16:55-63.
35. Uejima H, Mitsuya K, Kugoh H, Horikawa I, Oshimura M. Normal human chromosome 2 induces cellular senescence in the human cervical carcinoma cell line SiHa. Genes Chromosomes Cancer 1995;14:120-127.
36. Yoshida MA, Shimizu M, Ikeuchi T, Tonomura A, Yokota J, Oshimura M. In vitro growth suppression and morphological change in a human renal cell carcinoma cell line by the introduction of normal chromosome 3 via microcell fusion. Mol. Carcinog. 1994;9:114-121.
37. Poignee M, Backsch C, Beer K, Jansen L, Wagenbach N, Stanbridge EJ, Kirchmayr R, Schneider A, Durst M. Evidence for a putative senescence gene locus within the chromosomal region 10p14-p15. Cancer Res. 2001;61:7118-7121.
38. Reddy DE, Sandhu AK, DeRiel JK, Athwal RS, Kaur GP. Identification of a gene at 16q24.3 that restores cellular senescence in immortal mammary tumor cells. Oncogene 1999;18:5100-5017.
39. Uejima H, Shinohara T, Nakayama Y, Kugoh H, Oshimura M. Mapping a novel cellular-senescence gene to human chromosome 2q37 by irradiation microcell-mediated chromosome transfer. Mol. Carcinog. 1998;22:34-45.
40. Sasaki M, Honda T, Yamada H, Wake N, Barrett JC, Oshimura M. Evidence for multiple pathways to cellular senescence. Cancer Res. 1994;54:6090-6093.
41. Wang XW, Lin X, Klein CB, Bhamra RK, Lee YW, Costa M. A conserved region in human and Chinese hamster X chromosomes can induce cellular senescence of nickel-transformed Chinese hamster cell lines. Carcinogenesis 1992;13:555-561.
42. Sugrue MM, Shin DY, Lee SW, Aaronson SA. Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53. Proc. Natl. Acad. Sci. USA 1997;94:9648-9653.
43. Ling YH, Zou Y, Perez-Soler R. Induction of senescence-like phenotype and loss of paclitaxel sensitivity after wild-type p53 gene transfection of p53-null human non-small cell lung cancer H358 cells. Anticancer Res. 2000;20:693-702.
44. Jung MS, Yun J, Chae HD, Kim JM, Kim SC, Choi TS, Shin DY. p53 and its homologues, p63 and p73, induce a replicative senescence through inactivation of NF-Y transcription factor. Oncogene 2001;20:5818-5825.
45. Xu HJ, Zhou Y, Ji W, Perng GS, Kruzelock R, Kong CT, Bast RC, Mills GB, Li J, Hu SX. Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition. Oncogene 1997;15:2589-2596.
46. Fang L, Igarashi M, Leung J, Sugrue MM, Lee SW, Aaronson SA. p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53. Oncogene 1999;18:2789-2797.
47. Wang Y, Blandino G, Givol D. Induced p21waf expression in H1299 cell line promotes cell senescence and protects against cytotoxic effect of radiation and doxorubicin. Oncogene 1999; 18:2643-2649.
48. Dai CY, Enders GH. p16 INK4a can initiate an autonomous senescence program. Oncogene 2000;19:1613-1622.
49. Uhrbom L, Nister M, Westermark B. Induction of senescence in human malignant glioma cells by p16INK4A. Oncogene 1997; 15:505-514.
50. Fuxe J, Akusjarvi G, Goike HM, Roos G, Collins VP, Pettersson RF. Adenovirus-mediated overexpression of p15INK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A. Cell Growth Differ. 2000;11:373-384.
51. Tsugu A, Sakai K, Dirks PB, Jung S, Weksberg R, Fei YL, Mondal S, Ivanchuk S, Ackerley C, Hamel PA, Rutka JT. Expression of p57(KIP2) potently blocks the growth of human astrocytomas and induces cell senescence. Am. J. Pathol. 2000;157:919-932.
52. Goodwin EC, Yang E, Lee CJ, Lee HW, DiMaio D, Hwang ES. Rapid induction of senescence in human cervical carcinoma cells. Proc. Natl. Acad. Sci. USA 2000;97:10978-10983.
53. Wells SI, Francis DA, Karpova AY, Dowhanick JJ, Benson JD, Howley PM. Papillomavirus E2 induces senescence in HPV-positive cells via pRB- and p21(CIP)-dependent pathways. EMBO J. 2000;19:5762-5771.
54. Wilson HM, Birnbaum RS, Foot M, Quinn LS, Swisshelm K. Insulin-like growth factor binding protein-related protein 1 inhibits proliferation of MCF-7 breast cancer cells via a senescence-like mechanism. Cell Growth Differ. 2002;13:205-213.
55. Ravi RK, McMahon M, Yangang Z, Williams JR, Dillehay LE, Nelkin BD, Mabry M. Raf-1-induced cell cycle arrest in LNCaP human prostate cancer cells. J. Cell. Biochem. 1999;72:458-469.
56. Haq R, Brenton JD, Takahashi M, Finan D, Finkielsztein A, Damaraju S, Rottapel R, Zanke B. Constitutive p38HOG mitogen-activated protein kinase activation induces permanent cell cycle arrest and senescence. Cancer Res. 2002;62:5076-5082.
57. Engemann S, El Maarri O, Hajkova P, Oswald J, Walter J. Bisulfite-based methylation analysis of imprinted genes. Methods Mol. Biol. 2001;181:217-228.
58. Kinsella TM, Nolan GP. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum. Gene Ther. 1996; 7:1405-1413.
59. Nelson PJ, Werner T. Contributions of promoter modeling to gene target identification. Curr. Drug Disc. 2001;11:23-26.
60. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D. The human genome browser at UCSC. Genome Res. 2002;12:996-1006.
61. Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002;18:1427-1431.
62. Grunau C, Schattevoy R, Mache N, Rosenthal A. MethTools - a toolbox to visualize and analyze DNA methylation data. Nucleic Acids Res. 2000;28:1053-1058.
63. Tanaka H, Horikawa I, Kugoh H, Shimizu M, Barrett JC, Oshimura M. Telomerase-independent senescence of human immortal cells induced by microcell-mediated chromosome transfer. Mol. Carcinog. 1999;25:249-255.
64. Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA, Klingelhutz AJ. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 1998;396:84-88.
65. Wong LH, Sim H, Chatterjee-Kishore M, Hatzinisiriou I, Devenish RJ, Stark G, Ralph SJ. Isolation and characterization of a human Stat1 gene regulatory element. Inducibility by interferon (IFN) types I and II and role of IFN regulalory factor-1. J. Biol. Chem. 2002;277:19408-19417.
66. Yoneyama M, Suhara W, Fukuhara Y, Sato M, Ozato K, Fujita T. Autocrine amplification of type I interferon gene expression mediated by interferon stimulated gene factor 3 (ISGF3). J. Biochem. (Tokyo) 1996;120:160-169.
67. Pilz A, Ramsauer K, Heidari H, Leitges M, Kovarik P, Decker T. Phosphorylation of the Stat1 transactivating domain is required for the response to type I interferons. EMBO Rep. 2003;4:368-373.
68. Severino J, Allen RG, Balin S, Balin A, Cristofalo VJ. Is beta-galactosidase staining a marker of senescence in vitro and in vivo? Exp. Cell Res. 2000;257:162-171.
69. Yoshimura A. The CIS family: negative regulators of Jak-Stat signaling. Cytokine Growth Factor Rev. 1998;9:197-204.
70. Cooney RN. Suppressors of cytokine signaling (SOCS): inhibitors of the Jak/Stat pathway. Shock 2002;17:83-90.
71. Liu B, Liao J, Rao X, Kushner SA, Chung CD, Chang DD, Shuai K. Inhibition of Stat1-mediated gene activation by PIAS1. Proc. Natl. Acad. Sci. USA 1998;95:10626-10631.
72. Gorbunova V, Seluanov A, Pereira-Smilh OM. Evidence that high telomerase activity may induce a senescent-like growth arrest in human fibroblasts. J. Biol. Chem. 2003;278:7692-7698.
73. Roninson IB. Tumor cell senescence in cancer treatment. Cancer Res. 2003;63:2705-2715.
74. Mahboubi K, Pober JS. Activation of signal transducer and activator of transcription 1 (Stat1) is not sufficient for the induction of Stat1-dependent genes in endothelial cells. Comparison of interferon-gamma and oncostatin M. J. Biol. Chem. 2002;277: 8012-8021.
75. Gooch JL, Herrera RE, Yee D. The role of p21 in interferon gamma-mediated growth inhibition of human breast cancer cells. Cell Growth Differ. 2000;11:335-342.
76. Jenssen TK, Laegreid A, Komorowski J, Hovig E. A literature network of human genes for high-throughput analysis of gene expression. Nat. Genet. 2001;28:21-28.
77. 2+ and CaMKII for Stat1 Ser-727 phosphorylation in response to IFN-gamma. Proc. Natl. Acad. Sci. USA 2002;99:5971-5976.
78. Zhang J, Vinkemeier U, Gu W, Chakravarti D, Horvath C, Darnell J. Two contact regions between Stat1 and CBP/p300 in interferon-gamma signaling. Proc. Natl. Acad. Sci. USA 1996;93:15092-15096.
79. Look DC, Pelletier MR, Tidwell RM, Roswit WT, Holtzman MJ. Stat1 depends on transcriptional synergy with Sp1. J. Biol. Chem. 1995;270:30264-30267.
80. Ouchi T, Lee SW, Ouchi M, Aaronson SA, Horvath CM. Collaboration of signal transducer and activator of transcription 1 (Stat1) and BRCA1 in differential regulation of IFN-gamma target genes. Proc. Natl. Acad. Sci. USA 2000;97:5208-5213.